share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144：拟议出售证券
美股sec公告 ·  05/15 11:45
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer David Altshuler is set to sell 54 shares of common stock on 05/15/2024, with an aggregate market value of $23,270.22. The shares were acquired through an Employee Stock Purchase Plan (ESPP) on 05/14/2024, a day prior to the planned sale, and were paid for in cash. This transaction follows a three-month period where a total of 11,243 shares were sold by company insiders, generating gross proceeds of $4,754,697.42.
Vertex Pharmaceuticals Inc. officer David Altshuler is set to sell 54 shares of common stock on 05/15/2024, with an aggregate market value of $23,270.22. The shares were acquired through an Employee Stock Purchase Plan (ESPP) on 05/14/2024, a day prior to the planned sale, and were paid for in cash. This transaction follows a three-month period where a total of 11,243 shares were sold by company insiders, generating gross proceeds of $4,754,697.42.
Vertex Pharmicals Inc.高管戴维·阿尔舒勒定于2024年5月15日出售54股普通股，总市值为23,270.22美元。这些股票是在计划出售的前一天，即2024年5月14日通过员工股票购买计划（ESPP）收购的，并以现金支付。该交易是在为期三个月的时间内公司内部人士共出售11,243股股票之后进行的，总收益为4,754,697.42美元。
Vertex Pharmicals Inc.高管戴维·阿尔舒勒定于2024年5月15日出售54股普通股，总市值为23,270.22美元。这些股票是在计划出售的前一天，即2024年5月14日通过员工股票购买计划（ESPP）收购的，并以现金支付。该交易是在为期三个月的时间内公司内部人士共出售11,243股股票之后进行的，总收益为4,754,697.42美元。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息